- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030.
Apr. 10, 2026 at 3:35am
Got story updates? Submit your updates here. ›
A new generation of molecular data storage infrastructure aims to power the AI revolution by providing a more sustainable and scalable archival solution.Los Angeles TodayGenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology, have announced a strategic collaboration to industrialize DNA-based data storage. The partnership aims to address the challenge of existing archival storage systems reaching their economic and environmental limits by architecting the world's first molecular archival storage that requires no electricity to preserve data once encoded into DNA and can store massive volumes of information for centuries.
Why it matters
As the AI-driven surge in global data creation accelerates exponentially, existing archival storage systems built on magnetic tape and hard drives are reaching their economic and environmental limits. This collaboration between GenScript and Mimulus aims to transition molecular data storage from laboratory innovation to commercially scalable infrastructure, unlocking economically viable archival systems for global cloud and AI workloads.
The details
Under the agreement, GenScript will industrialize high‑throughput DNA synthesis at scale, targeting a leap from millions to billions of oligonucleotides synthesized in parallel on a single chip. This capability, combined with Mimulus' proprietary Molecular Archive Technology, enables molecular data storage to transition from being a 'scientific promise' into a 'global reality'. The collaboration seeks to dramatically accelerate the cost curve of DNA-based storage and unlock economically viable archival systems for global cloud and AI workloads.
- The strategic partnership between GenScript and Mimulus was announced on April 9, 2026.
- The collaboration aims to deliver breakthrough cost efficiencies in DNA-based data storage by 2030.
The players
GenScript Biotech Corporation
The world's leading provider of CMOS-based DNA synthesis technologies, founded in 2002 in New Jersey. GenScript accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products.
Mimulus Corp
A venture-backed biotechnology company pioneering Molecular Archive Technology, architecting the world's first economically sustainable and physically permanent archival infrastructure for the age of AI. Mimulus is making the future molecular.
Sherry Shao
Rotating CEO of GenScript Biotech Corporation.
Todd R. Nelson, Ph.D.
Founder and Chairman of Mimulus Corp.
What they’re saying
“When a new category emerges, the winners are built on infrastructure. At GenScript, we believe in Scripting Possibilities - turning what was once theoretical into scalable reality. DNA-based data storage will only become a viable real-world infrastructure when synthesis can be delivered at extraordinary throughput, quality, and cost. We are building that industrial foundation to transform molecular storage from being 'scientific promise' into 'global reality'.”
— Sherry Shao, Rotating CEO of GenScript Biotech Corporation
“Trying to solve a pressing 21st-century AI data problem with mid-century magnetic tape is a bit like trying to launch a rocket with a steam engine. But this isn't just about building a better storage device; it's about liquidating an operational liability to fuel the AI revolution. By combining our proprietary architecture with GenScript's unparalleled manufacturing scale, we are printing power permits. We are handing hyperscalers the exact megawatts they need to turn on their AI supercomputers today, unlocking a trillion-dollar flywheel that reshapes the economics of the cloud.”
— Todd R. Nelson, Ph.D., Founder and Chairman of Mimulus Corp
What’s next
The collaboration between GenScript and Mimulus aims to dramatically accelerate the cost curve of DNA-based storage and unlock economically viable archival systems for global cloud and AI workloads by 2030.
The takeaway
This partnership represents a significant step towards transitioning DNA-based data storage from a scientific concept to a commercially viable and scalable infrastructure, addressing the growing challenges of existing archival storage systems and enabling the continued growth and advancement of AI and cloud computing technologies.
Los Angeles top stories
Los Angeles events
Apr. 10, 2026
Emeline: Emotional Virgin World Tour 2026Apr. 10, 2026
LACUNA COIL: Sleepless Empire Tour 2026




